MINI REVIEW article
Front. Pharmacol.
Sec. Pharmacology of Anti-Cancer Drugs
Recent Advances in Gut Microbiota-based Nanotherapies for Cancer Treatment
Provisionally accepted
- 1Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, Zhejiang Province, China
- 2China Academy of Art, Hangzhou, Zhejiang Province, China
- 3China Pharmaceutical University, Nanjing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The effect of gut microbiota on carcinogenesis and progression has been demonstrated and arisen wide attention. Notably, specific microbial communities demonstrate dual therapeutic potential in enhancing anti-tumor treatment efficacy and mitigating chemotherapy-induced adverse effects, positioning microbial intervention as an innovative paradigm in oncology therapeutics. However, the clinical application of oral delivery of free-living gut microbiota faces significant challenges due to their inherent instability and premature clearance within the gastrointestinal tract. This biological limitation underscores the critical need for advanced delivery systems capable of preserving microbial viability and achieving targeted delivery. Nanotherapy, renowned for their precise targeting capabilities, exceptional biocompatibility, and enhanced pharmacokinetic profiles, have demonstrated transformative potential across biomedical applications, with several formulations already advancing to clinical implementation. Remarkably, current research on the delivery of gut microbiota for cancer treatment via nanotechnology remains limited and lacks comprehensive summarization. Therefore, this review systematically summarized recent advancements in gut microbiota-mediated nanotherapeutic strategies against cancer, proposing novel conceptual frameworks for synergistic microbiota-nanotherapy integration in cancer interventions.
Keywords: Gut Microbiota, Nanotherapy, Cancer, Synergetic therapy, Novel therapy
Received: 25 Apr 2025; Accepted: 25 Nov 2025.
Copyright: © 2025 Xu, Zhu, Zhao, Chai, Wu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Miaolian Wu
Mengmeng Zhang
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.